Site icon Hot Paths

Pfizer mulls US-led production amid tariff threat (PFE:NYSE)

Pfizer Makes $1.95 Billion Deal With U.S. For Future COVID-19 Vaccine

Jeenah Moon/Getty Images News

  • Pfizer (NYSE:PFE) CEO Albert Bourla says his company is well positioned to switch from overseas manufacturing facilities to domestic production sites if the Trump administration follows up on its plans to impose tariffs on pharmaceutical goods.
  • During a private meeting
Exit mobile version